Secondary Logo

Journal Logo

Unique imaging findings in fibromuscular dysplasia of renal arteries

A case report

Kong, Weiying, MD; Hu, Zhangxue, MD*

Section Editor(s): NA.,

doi: 10.1097/MD.0000000000012815
Research Article: Clinical Case Report
Open

Rationale: Fibromuscular dysplasia (FMD) is a rare vascular disorder that causes abnormal cell growth in arterial walls. The classic “string of beads” sign has been reported in many cases, whereas the appearance of tubular stenosis and distal tapering of renal arteries with multiple renal infarctions, as well as left kidney atrophy occurring in one patient, has not been precisely described.

Patient concerns: A 19-year-old woman presented to us with a history of elevated blood pressure without any symptoms for the past 1 month. Routine laboratory tests indicated a moderately impaired renal function, and ultrasound examination demonstrated a small-sized left kidney and seriously decreased blood flow of the left renal artery and its branches.

Diagnosis: Subsequent contrast-enhanced computed tomographic angiography (CTA) demonstrated multiple ischemic infarctions in the bilateral kidneys, and FMD was suggested at that time. Thereafter, we performed selective reno-angiography, which confirmed that the all left renal arteries had tubular stenosis and that right renal arterial branches presented distal tapering.

Intervention: Antihypertensive drugs were prescribed conservatively, including nifedipine 60 mg/d and prazosin 4 mg/d, to lower the patient's blood pressure.

Outcomes: The patient had a well-controlled blood pressure and an improved renal function at her 6-month follow-up.

Lessons: We should take the diagnosis of FMD into account if young women develop asymptomatic hypertension. To our knowledge, this is the first case that exhibited renal artery FMD manifesting as tubular stenosis and distal tapering, especially followed by bilateral renal infarctions and significant atrophy of the left kidney. In addition, CTA combined with digital subtraction angiography (DSA) may be more sensitive than other tests with respect to the detection of intrarenal infarctions and arterial variants of FMD.

Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Correspondence: Zhangxue Hu, Department of Nephrology, West China Hospital, National Key Laboratory of Biotherapy of Human Diseases, Sichuan University, #37 Guoxue Alley, Wuhou district, Chengdu 610041, Sichuan Province, China, (e-mail: hzxawy@scu.edu.cn).

Abbreviations: 3D = three-dimensional, CRP = C-reactive protein, CTA = computed tomographic angiography, DSA = digital subtraction angiography, FMD = fibromuscular dysplasia, GFR = glomerular filtration rate, LDH = lactate dehydrogenase, SCr = serum creatinine.

Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee at which the studies were conducted and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent: Written informed consent for publication of clinical details and images were obtained from the patient. A copy of the consent form is available for review upon request

The authors have no funding and conflicts of interest to disclose.

This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0

Received June 10, 2018

Accepted September 20, 2018

Back to Top | Article Outline

1 Introduction

Fibromuscular dysplasia (FMD) is a noninflammatory, nonatherosclerotic disease of the arterial wall musculature that commonly involves the renal, extracranial carotid, and vertebral arteries.[1–3] Areas involving the arteries can thicken, enlarge, narrow, and even can manifest as tapering, making it difficult for blood to flow through. The classic “string of beads” appearance has been described in many cases; however, the appearance of tubular stenosis and distal tapering with bilateral renal infarctions has not been precisely described, to the best of our knowledge. Here we report a rare case of a young female with a history of hypertension whose renal arteries manifested as typical tubular stenosis and distal tapering with multiple ischemic infarctions of the bilateral kidney as well as an atrophic left kidney on imaging. The patient was treated conservatively with antihypertensive drugs and found to have a well-controlled blood pressure as well as improved renal function at her 6-month follow-up.

Back to Top | Article Outline

2 Case report

A 19-year-old female presented to us with a history of elevated blood pressure for 1 month. She had been feeling well until a routine physical examination performed 1 month before her presentation showed that her blood pressure was 197/138 mmHg. She denied experiencing fever, arthralgia, dizziness, nausea, vomiting, or gross hematuria. On admission, her blood pressure was 183/131 mmHg with a heart rate of 83 beats/min. No abdominal bruits were auscultated. Routine laboratory tests showed that her serum creatinine (SCr) level was 1.5 mg/dL, the levels of serum C-reactive protein (CRP) and lactate dehydrogenase (LDH) were in the normal range, and the aldosterone-to-renin ratio (ARR) was 5.16 ng/dL per ng/(mL·h). Her urinalysis was normal, and the urinary protein excretion was 590 mg/24 h. Other tests such as evaluation of leukocyte, blood lipid, and hepatitis marker levels and immunological evaluations revealed negative results. Echocardiography showed that the left ventricle was hypertrophic, and duplex ultrasonography of the carotid arteries revealed the presence of a thickened intima-media at the origin of the right subclavian artery. Further renal ultrasonography indicated that the left kidney was significantly atrophic (6.3 × 3.5 × 3.7 cm) and that the blood flow to the kidney from the left renal artery and its branches was severely impaired, with the peak systolic velocity of the left renal artery being 46.6 cm/s and the peak velocity of the segmental arteries being 29.6 cm/s. In addition, both kidneys were determined to have a decreasing glomerular filtration rate (GFR: left kidney, 12.6 mL/min; right kidney, 30.7 mL/min). Computed tomographic angiography (CTA) was performed subsequently, which revealed multiple ischemic infarctions, partial cortical thinning, and irregular jagged edges in the bilateral kidneys (Fig. 1A, B). Meanwhile, three-dimensional (3D) reconstruction revealed that the left renal artery was much thinner and smaller than the right (Fig. 1C–D, arrows). FMD was suggested at that time, and selective reno-angiography was performed, which confirmed that tubular stenosis of the left renal artery extended into the branches (Fig. 2A). Although there was no obvious stenosis in the right renal artery, distal tapering was clearly seen at its branches (Fig. 2B). In addition, thrombus formations at the branches of the right artery were observed on imaging (Fig. 2B). The patient was therefore diagnosed with “tubular and tapering” FMD. Considering that the left renal artery and its branches all had severe tubular stenosis, nifedipine at 60 mg/d and prazosin at 4 mg/d were prescribed to lower the patient's blood pressure. Her blood pressure was controlled at 138/89 mmHg and SCr level was 1.3 mg/L when she was discharged. During the subsequent 6-month follow-up, her blood pressure remained well controlled and SCr level was stable.

Figure 1

Figure 1

Figure 2

Figure 2

Back to Top | Article Outline

3 Discussion

FMD, initially described in 1938 by Leadbetter and Burkland, is a rare noninflammatory, nonatherosclerotic vascular disorder that causes abnormal cell growth in arterial walls. As a result of abnormal cell growth in the arterial walls, areas of the arteries can thicken, enlarge, narrow, and even can manifest as tapering, making it difficult for blood to flow through. It can affect every artery in the body, but usually affects the renal, extracranial carotid, and vertebral arteries.[1–3] It is important to note that FMD is a significant cause of renovascular hypertension, especially in young women. The histologic descriptions of medial, intimal, and adventitial FMD by Harrison and MCcormack in 1971[4] have been replaced with an angiographic classification system.[1,5] On the basis of pathological–angiographic correlations, Kincaid et al proposed the following 3 types of renal artery stenosis of FMD: multifocal (string-of-beads appearance), unifocal (solitary stenosis <1 cm in length), and tubular (stenosis ≥1 cm in length).[6] Specifically, FMD may also manifest as aneurysm, dissection, occlusion, arterial tortuosity as well as distal tapering on angiographic imaging.[7] Tubular stenosis is characterized by the presence of an elongated, smooth, concentric narrowing of the renal artery caused mainly by medial hyperplasia and intimal fibroplasia.[6] This Chinese patient presented with renovascular hypertension, and comprehensive examinations showed significant tubular stenosis of the left renal arteries and distal tapering of the branches of the right artery with marked atrophy of the left kidney, as well as bilateral renal infarctions, but normal levels of CRP and LDH. There was no evidence of extrarenal artery stenosis, nor was there evidence of an immune disorder. All of the above findings confirmed the diagnosis of FMD.

Interestingly, CTA and 3D reconstruction demonstrated the presence of heterogeneously enhancing lesions, multiple filling defects, partial cortical thinning, and irregular jagged edges. The above findings proved that there were multiple ischemic infarctions in both kidneys, which is a rare complication of FMD that results from tubular stenosis, distal tapering, as well as thrombi.[8–13] It should be noted that bilateral renal infarctions are much less common than unilateral renal infarctions.[8–10,14,15] Acute large renal infarctions usually present with abdominal and flank pain, as well as fever, nausea, vomiting, hypertension, elevated LDH, and leukocytosis. Microscopic hematuria and mild proteinuria may be noted on urinalysis. SCr levels may increase if the infarctions are bilateral and involve important branches. Although this patient had suffered multiple renal infarctions and had developed severe left renal arteries stenosis, the right main renal artery was patent, which may explain why she was able to maintain moderate renal function despite her disease. The patient was virtually asymptomatic, which suggests that her infarctions happened over a long period of time. It is notable that, although invasive angiography is the gold standard for diagnosing FMD, the infarcted area seemed to be more obvious on 3D-CTA than on invasive angiography. The combination of CTA and DSA may be more sensitive than other tests with respect to the detection of intrarenal infarctions, as well as arterial “tubular and tapering” variants of FMD.

Back to Top | Article Outline

Author contributions

Conceptualization: Weiying Kong.

Data curation: Weiying Kong, Zhangxue Hu.

Formal analysis: Weiying Kong, Zhangxue Hu.

Methodology: Zhangxue Hu.

Project administration: Weiying Kong, Zhangxue Hu.

Software: Weiying Kong.

Supervision: Zhangxue Hu.

Writing – original draft: Weiying Kong, Zhangxue Hu.

Writing – review and editing: Weiying Kong, Zhangxue Hu.

Weiying Kong orcid: 0000-0003-0053-4152.

Back to Top | Article Outline

References

[1]. Olin JW, Gornik HL, Bacharach JM, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation 2014;129:1048–78.
[2]. Persu A, Giavarini A, Touze E, et al. European consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens 2014;32:1367–78.
[3]. Shivapour DM, Erwin P, Kim E. Epidemiology of fibromuscular dysplasia: a review of the literature. Vasc Med 2016;21:376–81.
[4]. Harrison EG Jr, McCormack LJ. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc 1971;46:161–7.
[5]. Persu A, Touze E, Mousseaux E, et al. Diagnosis and management of fibromuscular dysplasia: an expert consensus. Eur J Clin Invest 2012;42:338–47.
[6]. Kincaid OW, Davis GD, Hallermann FJ, et al. Fibromuscular dysplasia of the renal arteries. Arteriographic features, classification, and observations on natural history of the disease. Am J Roentgenol Radium Ther Nucl Med 1968;104:271–82.
[7]. Narula N, Kadian-Dodov D, Olin JW. Fibromuscular dysplasia: contemporary concepts and future directions. Prog Cardiovasc Dis 2018;60:580–5.
[8]. Salifu MO, Gordon DH, Friedman EA, et al. Bilateral renal infarction in a black man with medial fibromuscular dysplasia. Am J Kidney Dis 2000;36:184–9.
[9]. Doody O, Adam WR, Foley PT, et al. Fibromuscular dysplasia presenting with bilateral renal infarction. Cardiovasc Intervent Radiol 2009;32:329–32.
[10]. Dursun B, Yagci B, Batmazoglu M, et al. Bilateral renal infarctions complicating fibromuscular dysplasia of renal arteries in a young male. Scand J Urol Nephrol 2012;46:73–7.
[11]. Stinchcombe SJ, Manhire AR, Bishop MC, et al. Renal arterial fibromuscular dysplasia: acute renal infarction in three patients with angiographic evidence of medial fibroplasia. Br J Radiol 1992;65:81–4.
[12]. Siegelbaum MH, Weiss JP. Renal infarction secondary to fibrous dysplasia and aneurysm formation of renal artery. Urology 1990;35:73–5.
[13]. Barbey F, Matthieu C, Nseir G, et al. A young man with a renal colic. J Intern Med 2003;254:605–8.
[14]. Basile C, Lisi P, Chimienti D, et al. Fibromuscular dysplasia of renal arteries presenting with bilateral renal infarction in a young man. J Nephrol 2013;26:945–8.
[15]. Ayach T, Kazory A. Bilateral renal infarction: an uncommon presentation of fibromuscular dysplasia. Clin Kidney J 2013;6:646–9.
Keywords:

distal tapering; fibromuscular dysplasia; renovascular hypertension; tubular stenosis

Copyright © 2018 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.